are E-Cigarette Flavors associated with Exposure to Nicotine and Toxicants? Findings from Wave 2 of the Population assessment of Tobacco and health (PaTh) Study.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Smith (2019)
Differences in Exposure to Nicotine, Tobacco-Specific Nitrosamines, and Volatile Organic Compounds among Electronic Cigarette Users, Tobacco Smokers, and Dual Users from Three Countries.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Smith (2020)
Main and Interactive Effects of Nicotine Product Type on Sleep health among Dual Combustible and E-Cigarette Users.
Individual Clinical
Safety
Adverse Effects
So (2021)
Nicotine absorption from e-cigarettes over 12 months.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Soar (2019)
IqOS exposure impairs human airway cell homeostasis: direct comparison with traditional cigarette and e-cigarette
Individual Clinical
Biomarkers
Biomarkers Of Harm
Sohal (2019)
Vaping effects on asthma: results from a web survey and clinical investigation.
Individual Clinical
Safety
Adverse Effects
Solinas (2020)
Rapid Brain Nicotine Uptake from Electronic Cigarettes.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Solingapuram (2020)
hydroxyl Radicals in E-Cigarette Vapor and E-Vapor Oxidative Potentials under Different Vaping Patterns.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Son (2019)
Investigating E-Cigarette Particle Emissions and human airway Depositions under Various E-Cigarette-Use Conditions.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Son (2020)
Biomarkers of Exposure and Effect in the Lungs of Smokers, Nonsmokers, and Electronic Cigarette Users.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Song (2020)